Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.

By V. Beral, R. Doll, C. Hermon, R. Peto, G. Reeves. The Lancet, 2008

750 citations recorded by the source corpus.

Subfields: Genetics, Public Health, Environmental and Occupational Health, Reproductive Medicine

View Paper: https://www.semanticscholar.org/paper/489e336af70dae7320b98f2bae550249be14d0c0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. Lindsey A. Torre
2. A. Jemal
3. R. Siegel

In Public Health, Environmental and Occupational Health

1. R. Siegel
2. A. Jemal
3. Elizabeth E. Ward

Citations in the corpus

• Global Cancer in Women: Burden and Trends (2017, background): “Use of oral contraceptives is estimated to reduce ovarian cancer risk by as much as 30% in everusers, withgreaterrisk reduction inlong-termusers(89).”